Precision BioSciences Inc (DTIL) support and resistance · rev $10.8M
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
This page maps Precision BioSciences Inc (DTIL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.
DTIL currently screens at market cap $48.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DTIL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DTIL quote page for the session range and the stock page for the full model.
Not investment advice.